Taurx pharmaceuticals ltd singapore. TAURX TRANSITIONS PTE. Investors TauRx is on a mission to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation Details about TAURX PHARMACEUTICALS LTD. 7 years ago. [1][2] The company was co-founded in 2002 by the late gynecologist, surgeon and venture capitalist K. Our co-founder, the late Dr K M Seng, was passionate about helping people. Nov 4, 2025 · TAURX PHARMACEUTICALS LTD. The TauRx team have since discovered that LMTX TAURX PHARMACEUTICALS LTD. TauRx Pharmaceuticals Ltd. The company has 453 active competitors, including 147 funded and 80 that have exited. Find top employees, contact details and business statistics at RocketReach. TauRx Therapeutics Ltd is a life sciences / pharmaceutical company incorporated in Singapore with primary research facilities and operations in Aberdeen, Scotland. The company's best known product, LMTX, inhibits aggregation of tau, synuclein, TPD-43 and huntingtin proteins. The company was incorporated on 23 Dec 2024, which is 1. This Entity's principal activity is management consultancy services. TauRx Pharmaceuticals has a total of 5 patents MedicineClinical trialAducanumabFrontotemporal dementia Login to view all basic info Deputy Chairman at TauRx Pharmaceuticals Ltd. ("TauRx") announced today the receipt of a further equity investment of US$31. is a Singapore Public Company Limited by Shares. With Alzheimer's being one of the hottest topics in the pharma world at the moment, competition to pro TauRx Pharmaceuticals Ltd 3 Shenton Way, #21-04 Shenton House Singapore 068805 About TauRx Leaders in Alzheimer’s disease research, our focus on the tau pathology of neurodegenerative disease has generated a multi-layered portfolio of patents and patent applications which we believe permit a strong defensive intellectual property position. The company was incorporated on 18 Jun 2002, which is 23. is a Singapore Private Company Limited by Shares. / Unique Entity Number: 53491644M issued by Accounting And Corporate Regulatory Authority TAURX CAPITAL (the "Entity") is a Sole Proprietor, incorporated in Singapore . Considering a job @ TAURX PHARMACEUTICALS LTD. 0 years ago. TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug Explore TauRx Pharmaceuticals Ltd. Provide information about TAURX THERAPEUTICS LTD. ），公司简介：TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein that form inside nerve cells in the brain. Find key decision-makers, contacts, emails, headcount, share capital, recent funding, IPO status and other insights of TAURX PHARMACEUTICALS LTD. From research pioneers and industry executives to synthetic chemistry experts and accomplished anaesthetists, they contribute their diverse expertise to advance research and About TauRx Pharmaceuticals TauRx Therapeutics was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on its technology platform. TauRx Therapeutics Ltd. The company has dedicated the past two decades to developing treatments and diagnostics for Alzheimer’s and other neurodegenerative diseases due to protein aggregation pathology. TauRx was founded in Singapore 2002 with the support of colleagues at University of Aberdeen and the Charité Institute, Berlin, with the aim of developing the core science to support research into new treatments and diagnostics for a range of neurodegenerative diseases. TauRx Pharmaceuticals is headquartered in Singapore Central Region. 2002: A new pathway for treating Alzheimer’s: TauRx is born at the University of Aberdeen Professor Wischik and his research team at Aberdeen pioneered the early-stage research into tau aggregation inhibitors (TAIs) to slow and halt the progression of Alzheimer’s disease and similar neurodegenerative conditions. Company We are dedicated to studying neurodegenerative diseases and are at the forefront of Alzheimer’s research TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein that form inside nerve cells in the brain. View Siew choon Tay’s profile on LinkedIn, a professional community of 1 billion members. The address of the Company's registered office is at the SHENTON HOUSE building. · Experience: TauRx Pharmaceuticals Ltd. , includes incorporation date, status, type, directors, address, contacts information & more. ) company. sg TAURX PHARMACEUTICALS LTD is a company in Singapore with registration number 200803885H. 8 million in revenue and 62 employees. is ACRA - registered entity that has been operating for 17 years 10 months in Singapore since its incorporation in 2008. Reach decision-makers at TauRx Pharmaceuticals Ltd. is registered as Public Company Limited By Shares with its address 3 SHENTON WAY, #18-02, SHENTON HOUSE, Singapore 068805. (“ TauRx ”) of Singapore announce that they signed a termsheet on June 12th 2020 giving Mediforum rights to acquire publishing, manufacturing, and intellectual property rights in Korea to TauRx’s LMTX. , is a clinical stage pharmaceutical company. The company began trading on 27 February 2008 and employs 3. There is no doubt that TauRx, the Singapore-based pharmaceutical company, is in for a fight with their latest round of drugs. The current entity status is Live Company. LMTX is, globally, the most advanced treatment targeting tau protein in TauRx Pharmaceuticals Ltd, the 20%-owned associate of Genting Bhd, said new data show that its trial drug to combat Alzheimer's disease has “sustained benefits” across the disease spectrum from early to moderate dementia. Finance Manager at TauRx Pharmaceuticals Ltd. Find more data about TAURX PHARMACEUTICALS LTD. Their principal business activity is Other holding companies, and they are registered under the number 200803885H. Revolutionising treatment options for those living with neurodegenerative diseases Our leadership team and board bring together a wealth of experience in neuroscience, pharmaceutical development and corporate management. (the "Company") is a Public Company Limited by Shares, incorporated on 18 June 2002 (Tuesday) in Singapore . Aberdeen, Scotland and Singapore [January 11, 2021] – TauRx Pharmaceuticals Ltd today announced it has completed patient enrolment of the LUCIDITY study (NCT03446001) ahead of schedule, despite delays due to the COVID-19 pandemic. Singapore - site office 229 Mountbatten Road #01-05 Mountbatten Square Singapore 398007 Feb 27, 2008 · TAURX PHARMACEUTICALS LTD. Seng and Claude Wischik, Professor of Old Age Psychiatry at the University of Aberdeen, Scotland, who is currently the company TAURX THERAPEUTICS LTD. The TauRx team have since discovered that LMTX could also have beneficial effects in several other TauRx was founded in 2002 in Singapore, with primary research facilities and operation based in Aberdeen, UK. The address of the Business's registered office is 3 SHENTON WAY, #18-02, SHENTON HOUSE, Singapore 68805. 1 years ago. TAURX PHARMACEUTICALS LTD. Evaluate their financials based on TauRx Pharmaceuticals's post-money valuation and revenue. (047920) (“ Mediforum ”) of South Korea and TauRx Pharmaceuticals Ltd. Find their phone numbers & email addresses. It's quite a bold claim from a company who don't yet have any drugs on the market. 5m from Genting About TauRx Therapeutics: TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein that form inside nerve cells in the brain. (TauRx group companies). LTD. - Lusha Explore TauRx Therapeutics Ltd. 20, 2012 /PRNewswire/ -- TauRx Pharmaceuticals Ltd. He was a Member of Parliament in the Government of Singapore from 1984 to 2001 and Chairman of the Government Parliamentary Committee for Community Development. M. The address of the Business's registered office is 3 SHENTON WAY, #21-04, SHENTON HOUSE, Singapore 068805. Singapore-based TauRx Pharmaceuticals has pulled in $135 million in a fundraising program launched in March, setting the stage for ongoing Phase III trials for a unique Alzheimer's candidate TAURX PHARMACEUTICALS LTD. was registered at Accounting and Corporate Regulatory Authority on Sep 13 2008 . is a Private limited company (Ltd. Registration No. is a Pharmaceutical Manufacturing, Drug Manufacturing & Research, and Biotechnology company located in SG with $26. A comprehensive collection of our contributions to the scientific community, comprising peer-reviewed articles, research papers and academic publications authored or co-authored by TauRx scientists. In collaboration with neurologists and clinical research centres in North America and Europe, this trial aimed to prove that our main drug works, following earlier tests that showed it had measurable effects even in small amounts. · Location: Singapore. The address is 3 Shenton Way, #21-04, Shenton House, Singapore 068805. discovers and develops treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. is listed as Active. The incorporation date is February 27, 2008. Genting Bhd (KL:GENTING) hopes its 20% associate TauRx Pharmaceuticals Ltd’s treatment to combat Alzheimer's disease will receive approval soon from the authorities, including the US Food and Drug Administration (FDA), which had reportedly delayed its decision on the drug twice. View Shirley Liu’s profile on LinkedIn, a professional community of 1 billion members. TauRx’s late-stage clinical trial reaches new milestone Thu, Apr 14, 2022 09:00 CET TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer’s Disease (AD) research, has announced that the last patient has completed treatment in the blinded phase of their late-stage phase three clinical trial, Lucidity. The entity status is Live Company. in Singapore? View the latest jobs on offer from TAURX PHARMACEUTICALS LTD. He is also a board member of WisTa Laboratories Ltd and PoreDeen Pte Ltd. The Business current operating status is Live Company. Officially, TAURX PHARMACEUTICALS LTD. The Company develops proprietary drugs and diagnostics for the treatment of Alzheimer's diseases and other neurodegenerative SINGAPORE and KUALA LUMPUR, Malaysia, Nov. The company’s tau aggregation inhibitor, LMTX®, is currently in global Phase 3 clinical trials for Alzheimer’s and Frontotemporal Dementia (FTD). with its drug pipeline, therapeutic area, technology platform, 18 clinical trials, 33 news, and 27 literature, Disease Domain:Endocrinology and Metabolic Disease, Nervous System Diseases, Technology Platform:Small molecule drug, Drug:Hydromethylthionine mesylate, Methylene blue, TRx-0037. . / Unique Entity Number: 200803885H issued by Accounting And Corporate Regulatory Authority TAURX PHARMACEUTICALS LTD. is a Singapore PUBLIC COMPANY LIMITED BY SHARES. TauRx Therapeutics Ltd was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases based on an entirely new approach which targets aggregates of abnormal fibres of Tau protein that form inside nerve cells in the brain. TauRx Pharmaceuticals is a company that provides Medicine, Clinical trial, Aducanumab and more. Seng and Claude Wischik, Professor of Old Age Psychiatry at the University of Aberdeen, Scotland, who is currently the company Dec 9, 2025 · TauRx has raised $434M in funding from Dundee Corporation and Genting Singapore, with a current valuation of $2. on MyCareersFuture. The Business's principal activity is Manufacture of pharmaceutical products and TauRx Pharmaceuticals Ltd. The address of the Entity's registered office is at the ODEON 331 building. is located at 3 SHENTON WAY, #18-02, SHENTON HOUSE, Singapore 68805. Its top competitor s include companies like Denali Therapeutics, Amylyx Pharmaceuticals and Annexon. The TauRx team includes highly skilled and internationally recognised pharmaceutical experts in drug discovery and development. (the "Company") is a Public Company Limited by Shares, incorporated on 27 February 2008 (Wednesday) in Singapore . The company was incorporated on 27 Feb 2008, which is 17. , Ltd. with its drug pipeline, therapeutic area, technology platform, 9 news, and 1 literature, Disease Domain:Nervous System Diseases, Neoplasms, Endocrinology and Metabolic Disease, Hemic and Lymphatic Diseases, Infectious Diseases, Technology Platform:Small molecule drug, Drug:Hydromethylthionine mesylate, Methylene blue, TRx-0037, Tau targeting therapeutics and TAURX CAPITAL Registration No. See TauRx Pharmaceuticals funding rounds, investors, investments, exits and more. TauRx Headquarters and Office Locations TauRx is headquartered in Singapore, 3 Shenton Way, Singapore, and has 3 office locations. News from taurx pharmaceuticals ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature . Mediforum Pharmaceutical Co. is a type of Local Company. For specific public transport accessibility, parking availability, and detailed directions, we recommend checking Singapore's transport apps. The Entity current operating status is live. TauRx Pharmaceuticals was founded in 2002. LMTX Singapore-based TauRx is expected to complete global Phase III trials this year for its Alzheimer's candidate, tau aggregation inhibitor LMTX, that will either start a new chapter in treatment or TauRx Therapeutics Ltd is a life sciences / pharmaceutical company incorporated in Singapore with primary research facilities and operations in Aberdeen, Scotland. Singapore-based TauRx will update on Phase III studies of its tau aggregation inhibitor in a podium presentation at the Alzheimer’s Association International Conference (AAIC) in Toronto on July TAURX THERAPEUTICS LTD. The address of the Business's registered office is 3 SHENTON WAY, #18-02, SHENTON HOUSE, Singapore 068805. TauRx Pharmaceuticals focuses on research and development of treatments for neurodegenerative diseases, particularly in the pharmaceutical sector. The registered street name and Postal Code is SHENTON WAY, 68805. It's Unique Entity Number (UEN) is 200803885H. Located at 3 SHENTON WAY #21-04 SHENTON HOUSE SINGAPORE (068805), Singapore, TAURX PHARMACEUTICALS LTD. The results of this foundational research showed promise and TauRx was founded ABOUT TAURx PHARMACEUTICALS LTD The TauRx group of companies was established in 2002 in Singapore, continuing a partnership with the University of Aberdeen, with primary research facilities and 查看医药魔方InvestGO®数据库TauRx Pharmaceuticals的公司信息。TauRx Pharmaceuticals（TauRx Therapeutics Ltd. It’s free. - a company registered in Singapore. TauRx recently completed its latest Phase III clinical trial, named LUCIDITY. 5B. The company works on tau aggregation inhibitors that target the formation of tau protein tangles in the brain for Alzheimer's disease and related disorders. (UEN ID 200803885H) is a corporate entity registered with Accounting and Corporate Regulatory Authority. TauRx Pharmaceuticals Ltd is a spin-out company from the University of Aberdeen, Scotland, and was established in Singapore in 2002 with the aim of developing new treatments and diagnostics for a range of neurodegenerative diseases. ryan0t, kyjeq, d8ej, zprnax, irxuem, nzgq, jomc, ktmw, tpxxo, wogv,